Heart involvement in cystic fibrosis: A specific cystic fibrosis-related myocardial changes?

Fabien Labombarda1, Eric Saloux1, Jacques Brouard2

  • 1Caen CHU, Department of Cardiology, Caen, F-14000, France.

Respiratory Medicine
|September 1, 2016
PubMed

Insights

Cystic fibrosis (CF) can affect the heart, causing dysfunction. Echocardiography reveals this cystic fibrosis-related cardiomyopathy, influenced by hypoxemia and inflammation, impacting patient risk stratification.

Area of Science:

  • Cardiology
  • Pulmonology
  • Genetics

Background:

  • Cystic fibrosis is a multi-systemic disease with progressive organ dysfunction.
  • Evidence suggests myocardial involvement in cystic fibrosis, termed cystic fibrosis-related cardiomyopathy.
  • Hypoxemia, inflammation, and CFTR dysfunction are implicated in cardiac issues.

Purpose of the Study:

  • To review evidence for and against heart involvement in cystic fibrosis.
  • To explore the mechanisms and prognostic implications of cystic fibrosis-related cardiomyopathy.
  • To synthesize findings from echocardiographic studies on cardiac function in CF.

Main Methods:

  • Literature review focusing on echocardiographic studies.
  • Analysis of pathological, experimental, and clinical evidence.
  • Synthesis of data on ventricular dysfunction in cystic fibrosis patients.

Main Results:

  • Echocardiography demonstrates diastolic and/or systolic ventricular dysfunction in cystic fibrosis.
  • Hypoxemia and inflammation are key factors in cardiac involvement.
  • Cystic Fibrosis Transmembrane Regulator (CFTR) plays a role in cardiomyocyte function.

Conclusions:

  • Cystic fibrosis-related cardiomyopathy is a recognized entity.
  • Cardiac function assessment aids in risk stratification and treatment decisions for CF patients.
  • Further investigation into heart involvement in CF is warranted.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
618
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
535
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
1000
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
3.4K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
582
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
716